As multiple Indian pharma companies race to launch cheaper semaglutide versions, doctors warn that while affordability could transform diabetes and obesity management, misuse, unrealistic expectations, and off-label cosmetic use remain real risks. Experts highlight spikes in patient enquiries, potential rebound weight gain, and the influence of celebrity transformations, stressing that the drug is effective, but not a magic fix, and must be paired with lifestyle changes and medical supervision.
News
Pharma Companies Rush Cheap Semaglutide Shots to India, Experts Warn “Not a Magic Fix”
March 21, 2026As multiple Indian pharma companies race to launch cheaper semaglutide versions, doctors warn that while affordability could transform diabetes and obesity management, misuse, unrealistic expectations, and off-label cosmetic use remain real risks. Experts highlight spikes in patient enquiries, potential rebound weight gain, and the influence of celebrity transformations, stressing that the drug is effective, but not a magic fix, and must be paired with lifestyle changes and medical supervision.